SCHEDULE 13D

Company

IRONWOOD PHARMACEUTICALS INC

Filed

May 16, 2019

Accession Number

0000899140-19-000402

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →